Mirum Pharmaceuticals target price raised to $156 from $136
MIRM•Stifel raised its target price for Mirum Pharmaceuticals to $156 from $136.
Related News
Commercial Metals jumps after Q4 results beat estimates
CMC•
Plug Power Q3 2026 net cash usage falls to approximately $28 million on preliminary estimates
PLUG•
China’s EU car cuts roar confidence, not climbdown
BYD•
Morgan Stanley target price cut to $217 from $223 by Wells Fargo
MS•
Charles Schwab Q3 revenue up 17%, slightly misses estimates
SCHW•